Lexotan Dosage/Direction for Use

Standard dosage: Average dosing for outpatient therapy: 1.5-3 mg up to three times daily.
Severe cases, especially in hospital: 6-12 mg two or three times daily.
These amounts are general recommendations, and dosage should be individually determined.
Treatment of outpatients should begin with low doses, gradually increasing to the optimum level.
Duration of Treatment: The duration of treatment should be as short as possible. The patient should be reassessed regularly and the need for continued treatment should be evaluated, especially in case the patient is symptom-free. The overall treatment generally should not be more than 8-12 weeks, including a tapering-off process. In certain cases, extension beyond the maximum treatment period may be necessary, if so, it should not take place without re-evaluation of the patient's status with special expertise.
The patient should be checked regularly at the start of treatment in order to minimize the dosage and/or the frequency of administration and to prevent overdose due to accumulation.
Special Dosage Instructions: Pediatric use: Bromazepam (Lexotan) is usually not indicated in children, but if the physician feels Bromazepam (Lexotan) treatment is appropriate, then the dose should be adjusted to their low body weight (about 0.1-0.3 mg/kg body weight).
Geriatric use: Elderly patients (see Use in Special Populations under Precautions and Pharmacology: Pharmacokinetics: Pharmacokinetics in Special Populations under Actions) require lower doses because of potentially increased sensitivity and changed pharmacokinetics.
Hepatic Impairment: Patients with severe hepatic impairment should not be treated with Bromazepam (Lexotan) tablets (see Contraindications).
In patients with mild or moderate hepatic impairment, the lowest dose possible should be given.